Tvardi Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Tvardi Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Tvardi Therapeutics Inc.
Rating: 1.89475
Author: Trendlyne DVM scores

about

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This p...

25.69 -0.29 (-1.12%)

25.12% Fall from 52W High

19,303

XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

4.0 / 100

Technically Bullish

71.8 / 100

1Yr Price target upside is 120%

7 analysts

Tvardi Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tvardi Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This p...

25.12% Fall from 52W High

SWOT Analysis

Tvardi Therapeutics Inc. Live Price Chart